Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network

During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Ludwig, Heinz, Delforge, Michel, Facon, Thierry, Einsele, Hermann, Gay, Francesca, Moreau, Philippe, Avet-Loiseau, Hervé, Boccadoro, Mario, Hajek, Roman, Mohty, Mohamad, Cavo, Michele, Dimopoulos, Meletios A, San-Miguel, Jesús F, Terpos, Evangelos, Zweegman, Sonja, Garderet, Laurent, Mateos, María-Victoria, Cook, Gordon, Leleu, Xavier, Goldschmidt, Hartmut, Jackson, Graham, Kaiser, Martin, Weisel, Katja, van de Donk, Niels W. C. J., Waage, Anders, Beksac, Meral, Mellqvist, Ulf H., Engelhardt, Monika, Caers, Jo, Driessen, Christoph, Bladé, Joan, Sonneveld, Pieter
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035147/
https://ncbi.nlm.nih.gov/pubmed/29720735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0040-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados